Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Orion OYJ Gross Profit 2017-2024 | ORINY

Orion OYJ annual/quarterly gross profit history and growth rate from 2017 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Orion OYJ gross profit for the quarter ending September 30, 2024 was $0.351B, a 88.37% increase year-over-year.
  • Orion OYJ gross profit for the twelve months ending September 30, 2024 was $0.931B, a 35.18% increase year-over-year.
  • Orion OYJ annual gross profit for 2023 was $0.712B, a 20.4% decline from 2022.
  • Orion OYJ annual gross profit for 2022 was $0.894B, a 27.38% increase from 2021.
  • Orion OYJ annual gross profit for 2021 was $0.702B, a 5.59% decline from 2020.
  
Orion OYJ Annual Gross Profit
(Millions of US $)
2023 $712
2022 $894
2021 $702
2020 $744
2019 $709
2018 $696
2017 $728
2016 $721
Orion OYJ Quarterly Gross Profit
(Millions of US $)
2024-09-30 $351
2024-06-30 $204
2024-03-31 $185
2023-12-31 $190
2023-09-30 $186
2023-06-30 $167
2023-03-31 $168
2022-12-31 $167
2022-09-30 $358
2022-06-30 $185
2022-03-31 $185
2021-12-31 $175
2021-09-30 $154
2021-06-30 $187
2021-03-31 $186
2020-12-31 $171
2020-09-30 $170
2020-06-30 $210
2020-03-31 $193
2019-12-31 $180
2019-09-30 $197
2019-06-30 $169
2019-03-31 $164
2018-12-31 $184
2018-09-30 $143
2018-06-30 $186
2018-03-31 $184
2017-12-31 $201
2017-09-30 $159
2017-06-30 $181
2017-03-31 $187
2016-12-31 $302
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.424B $1.288B
Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $73.684B 28.35
Chugai Pharmaceutical (CHGCY) Japan $69.441B 27.05
Takeda Pharmaceutical (TAK) Japan $41.205B 8.58
Merck (MKKGY) Germany $18.882B 16.91
Sandoz Group AG (SDZNY) Switzerland $18.766B 0.00
Astellas Pharma (ALPMY) Japan $17.138B 15.78
United Therapeutics (UTHR) United States $16.294B 16.03
Neurocrine Biosciences (NBIX) United States $14.266B 37.77
Summit Therapeutics (SMMT) United States $13.163B 0.00
Shionogi (SGIOY) Japan $12.012B 12.03
Madrigal Pharmaceuticals (MDGL) United States $7.392B 0.00
Ionis Pharmaceuticals (IONS) United States $5.283B 0.00
Corcept Therapeutics (CORT) United States $5.223B 39.56
Grifols, S.A (GRFS) Spain $5.012B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.764B 0.00
PTC Therapeutics (PTCT) United States $3.389B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.688B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.614B 11.85
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.469B 14.76
NewAmsterdam Pharma (NAMS) Netherlands $2.305B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.062B 0.00
Soleno Therapeutics (SLNO) United States $1.859B 0.00
Indivior (INDV) United States $1.634B 6.66
Dyne Therapeutics (DYN) United States $1.615B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.589B 0.00
Evotec AG (EVO) Germany $1.545B 0.00
Xencor (XNCR) United States $1.442B 0.00
Harrow (HROW) United States $1.306B 0.00
Ocular Therapeutix (OCUL) United States $1.291B 0.00
Guardian Pharmacy Services (GRDN) United States $1.266B 0.00
Ardelyx (ARDX) United States $1.201B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.155B 0.00
ARS Pharmaceuticals (SPRY) United States $1.092B 0.00
Enliven Therapeutics (ELVN) United States $1.062B 0.00
Collegium Pharmaceutical (COLL) United States $1.061B 5.79
Avadel Pharmaceuticals (AVDL) Ireland $0.761B 0.00
Cronos Group (CRON) Canada $0.757B 0.00
Bioventus (BVS) United States $0.753B 23.79
Relay Therapeutics (RLAY) United States $0.745B 0.00
USANA Health Sciences (USNA) United States $0.646B 11.97
Ironwood Pharmaceuticals (IRWD) United States $0.634B 0.00
Oruka Therapeutics (ORKA) United States $0.550B 0.00
Elite Pharmaceuticals (ELTP) United States $0.534B 0.00
Xeris Biopharma Holdings (XERS) United States $0.507B 0.00
Tourmaline Bio (TRML) United States $0.505B 0.00
Altimmune (ALT) United States $0.489B 0.00
OmniAb (OABI) United States $0.486B 0.00
Savara (SVRA) United States $0.477B 0.00
ProKidney (PROK) United States $0.472B 0.00
Verve Therapeutics (VERV) United States $0.468B 0.00
Esperion Therapeutics (ESPR) United States $0.461B 0.00
Siga Technologies (SIGA) United States $0.443B 5.17
Zevra Therapeutics (ZVRA) United States $0.433B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.432B 0.00
KalVista Pharmaceuticals (KALV) United States $0.388B 0.00
Akebia Therapeutics (AKBA) United States $0.382B 0.00
Organogenesis (ORGO) United States $0.378B 0.00
Korro Bio (KRRO) United States $0.330B 0.00
Aldeyra Therapeutics (ALDX) United States $0.294B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.286B 116.07
Jupiter Neurosciences (JUNS) United States $0.283B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.263B 15.63
4D Molecular Therapeutics (FDMT) United States $0.255B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.240B 0.00
Avita Medical (RCEL) United States $0.240B 0.00
Heron Therapeutics (HRTX) United States $0.236B 0.00
Larimar Therapeutics (LRMR) United States $0.234B 0.00
Profound Medical (PROF) Canada $0.227B 0.00
Lexeo Therapeutics (LXEO) United States $0.211B 0.00
Inhibikase Therapeutics (IKT) United States $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.190B 0.00
CytoDyn (CYDY) United States $0.183B 0.00
MediWound (MDWD) Israel $0.180B 0.00
VAXART, INC (VXRT) United States $0.180B 0.00
Silence Therapeutics (SLN) United Kingdom $0.179B 0.00
Lyell Immunopharma (LYEL) United States $0.176B 0.00
Aclaris Therapeutics (ACRS) United States $0.176B 0.00
Acrivon Therapeutics (ACRV) United States $0.170B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.144B 0.00
Cassava Sciences (SAVA) United States $0.136B 0.00
Nanobiotix S.A (NBTX) France $0.133B 0.00
Champions Oncology (CSBR) United States $0.131B 0.00
Telomir Pharmaceuticals (TELO) United States $0.122B 0.00
Metagenomi (MGX) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.116B 0.00
Protara Therapeutics (TARA) United States $0.115B 0.00
Inotiv (NOTV) United States $0.114B 0.00
ElectroCore (ECOR) United States $0.108B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.108B 0.00
Cardiol Therapeutics (CRDL) Canada $0.105B 0.00
Regulus Therapeutics (RGLS) United States $0.092B 0.00
Pyxis Oncology (PYXS) United States $0.092B 0.00
Karyopharm Therapeutics (KPTI) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Century Therapeutics (IPSC) United States $0.084B 0.00
Context Therapeutics (CNTX) United States $0.081B 0.00
Journey Medical (DERM) United States $0.080B 0.00
Assertio Holdings (ASRT) United States $0.080B 20.91
ESSA Pharma (EPIX) Canada $0.077B 0.00
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Avalo Therapeutics (AVTX) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Galectin Therapeutics (GALT) United States $0.069B 0.00
Unicycive Therapeutics (UNCY) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.066B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.063B 0.00
FibroGen (FGEN) United States $0.062B 0.00
Gain Therapeutics (GANX) United States $0.061B 0.00
AleAnna (ANNA) United States $0.060B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
OptiNose (OPTN) United States $0.053B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.052B 0.00
AlloVir (ALVR) United States $0.051B 0.00
VYNE Therapeutics (VYNE) United States $0.051B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.047B 0.00
Nutriband (NTRB) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.045B 0.00
Scienture Holdings (SCNX) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.041B 0.00
CASI Pharmaceuticals (CASI) China $0.040B 0.00
BioVie (BIVI) United States $0.039B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.033B 0.00
Incannex Healthcare (IXHL) Australia $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.030B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Mannatech (MTEX) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Traws Pharma (TRAW) United States $0.024B 0.00
DURECT (DRRX) United States $0.024B 0.00
Carisma Therapeutics (CARM) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Klotho Neurosciences (KLTO) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
SciSparc (SPRC) Israel $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Dominari Holdings (DOMH) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Conduit Pharmaceuticals (CDT) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.98